Get Adobe Flash player

Anthera continues Phase 2b PEARL-SC clinical study in SLE patients Anthera Pharmaceuticals, Inc ?läkemedelsföretag read more . , a biopharmaceutical organization developing drugs to take care of serious illnesses including cardiovascular and autoimmune disorders, today announced the continuation of the Phase 2b PEARL-SC clinical study following an interim analysis of all safety and efficacy data. Within the ongoing safety monitoring of the PEARL-SC clinical study, the business’s Data Safety Monitoring Board fulfilled for the fourth time since the start of the study to review all available patient security data.

Random articles
Other articles from "manual therapy":